Nature’s Sunshine Products (NATR) to Release Quarterly Earnings on Thursday

Nature’s Sunshine Products (NASDAQ:NATR) will likely be announcing its Q2 2026 results after the market closes on Thursday, August 6th. Analysts expect Nature’s Sunshine Products to post earnings of $0.27 per share and revenue of $123.7040 million for the quarter. Parties are encouraged to explore the company’s upcoming Q2 2026 earning summary page for the latest details on the call scheduled for Thursday, August 6, 2026 at 5:00 PM ET.

Nature’s Sunshine Products (NASDAQ:NATR) last announced its quarterly earnings results on Thursday, May 7th. The company reported $0.30 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.20 by $0.10. The business had revenue of $122.89 million for the quarter, compared to the consensus estimate of $122.15 million. Nature’s Sunshine Products had a return on equity of 14.67% and a net margin of 4.06%.

Nature’s Sunshine Products Trading Down 3.2%

NATR opened at $20.46 on Wednesday. The firm has a market cap of $359.69 million, a price-to-earnings ratio of 18.60 and a beta of 0.88. Nature’s Sunshine Products has a 12 month low of $12.97 and a 12 month high of $28.14. The stock has a fifty day moving average price of $20.78 and a 200-day moving average price of $23.60.

Insider Transactions at Nature’s Sunshine Products

In related news, EVP Kevin R. Herbert sold 2,000 shares of the stock in a transaction that occurred on Friday, June 12th. The shares were sold at an average price of $20.68, for a total value of $41,360.00. Following the transaction, the executive vice president owned 48,866 shares in the company, valued at approximately $1,010,548.88. This represents a 3.93% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Bryant J. Yates sold 11,968 shares of the firm’s stock in a transaction that occurred on Friday, June 5th. The stock was sold at an average price of $19.90, for a total transaction of $238,163.20. Following the transaction, the executive vice president directly owned 77,446 shares of the company’s stock, valued at $1,541,175.40. This represents a 13.38% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders have sold 35,696 shares of company stock worth $742,407. Insiders own 3.10% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the business. Raymond James Financial Inc. purchased a new stake in Nature’s Sunshine Products in the second quarter valued at $37,000. Centiva Capital LP purchased a new stake in shares of Nature’s Sunshine Products in the third quarter worth about $157,000. Algert Global LLC purchased a new stake in shares of Nature’s Sunshine Products in the third quarter worth about $160,000. Public Employees Retirement System of Ohio grew its holdings in Nature’s Sunshine Products by 76.9% during the third quarter. Public Employees Retirement System of Ohio now owns 10,791 shares of the company’s stock worth $167,000 after acquiring an additional 4,692 shares during the period. Finally, Occudo Quantitative Strategies LP acquired a new stake in Nature’s Sunshine Products during the third quarter worth about $173,000. Hedge funds and other institutional investors own 79.40% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts have issued reports on NATR shares. Weiss Ratings lowered Nature’s Sunshine Products from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Tuesday, June 9th. DA Davidson raised shares of Nature’s Sunshine Products to a “strong-buy” rating in a research report on Monday, July 6th. Finally, Canaccord Genuity Group lowered their price target on shares of Nature’s Sunshine Products from $37.00 to $36.00 and set a “buy” rating on the stock in a report on Thursday, July 30th. One equities research analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating and one has given a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Buy” and a consensus target price of $34.50.

About Nature’s Sunshine Products

Nature’s Sunshine Products, Inc is a global manufacturer and direct seller of nutritional supplements, herbal remedies, and personal care products. The company’s core business centers on research, development and distribution of vitamins, minerals, botanicals and essential oil-based formulations designed to support overall health and wellness. Operating under a network-marketing model, Nature’s Sunshine works through a network of independent distributors who promote and sell its product line directly to consumers.

The company’s product portfolio spans dietary supplements such as single-ingredient vitamins, proprietary herbal blends, sports nutrition formulas and weight-management solutions, along with skin and hair care items based on botanical extracts and essential oils.